Supply of Loratadine Tablets (Pharmaceutical Product Supply)

The contract entails the manufacture and supply of 10,000 packages of Loratadine Tablets, identified by NSN 6505013770448 and NDCs 00904-7511-61 and 51079-0246-20, to meet stringent FDA and Department of Defense regulatory requirements. The product must comply with all applicable pharmaceutical standards for safety, efficacy, and labeling as mandated by federal agencies, ensuring suitability for military and veterans' healthcare systems. The contract is classified as a subcontract under NAICS code 325412, indicating it falls within the pharmaceutical and medicine manufacturing sector. The award is managed by the Defense Logistics Agency under the Department of Defense, with the solicitation posted on July 14, 2026, and performance expected to align with DLA's supply chain protocols for medical materiel. The place of performance and specific delivery details are not enumerated, but the contract is linked to the official DIBBS system through its award number SPE2DX25D9900 and delivery order SPE2DP26F7473, signaling formal procurement and logistics tracking within the DoD framework. All units must be packaged, documented, and shipped in accordance with military logistics specifications to support deployment readiness and pharmaceutical inventory management.